Related Experiment Video
Updated: Jul 9, 2026

Isolation and Physiological Analysis of Mouse Cardiomyocytes
Published on: September 7, 2014
A case report-facing blues in cardiac amyloidosis: no more a zebra
Ranjit Kumar Nath1, Abhinav Shrivastava1
1Dr Ram Manohar Lohia Hospital and ABVIMS, 32/31 West Patel Nagar, New Delhi 110001, India.
Insights
Cardiac amyloidosis can present diversely. A patient with transthyretin amyloidosis experienced ischemic heart disease, cardiomyopathy, and heart block, requiring a novel pacemaker implantation strategy using coronary sinus lead placement.
Area of Science:
- Cardiology
- Cardiovascular Diseases
- Cardiac Electrophysiology
Background:
- Cardiac amyloidosis presents with a wide spectrum of clinical manifestations.
- This case highlights the full spectrum of cardiac amyloidosis involvement over a patient's lifetime.
Observation:
- A 65-year-old male with a history of ischemic heart disease presented with syncope, dyspnea, and edema.
- He developed complete heart block and restrictive cardiomyopathy, diagnosed as transthyretin amyloidosis (aTTR).
- Permanent pacemaker implantation was challenging due to lead-tissue interface disruption.
Findings:
- A novel strategy involving coronary sinus lead placement and proximal stenting successfully achieved pacing thresholds.
- Abdominal fat pad and cardiac biopsies confirmed aTTR amyloidosis.
Implications:
- Cardiac amyloidosis can mimic ischemic heart disease and lead to conduction abnormalities and cardiomyopathy.
- Pacemaker implantation in advanced amyloid cardiomyopathy presents unique challenges.
- Coronary sinus lead placement with stenting offers a viable solution for ventricular pacing in challenging cases.
Background:
Cardiac amyloidosis presentation in an affected individual can be varied. We describe a patient who had the entire spectrum of involvement in his life time. Initially presented as an ischaemic heart disease and later developed complete heart block (CHB) and frank cardiomyopathy. Increased load of amyloid caused lead-tissue interface disruption resulting in high pacing thresholds with difficulty in capture during permanent pacemaker implantation requiring a novel strategy of management.
Case Summary:
A 65-year-old male presented with two episodes of syncope with a history of gradually progressive dyspnoea of 6 months duration along with lower limb swelling for last 1-2 months. He had a history of drug-eluting stent implantation for stable ischaemic heart disease 4 years back. Now he presented with a CHB and a transthoracic echocardiogram hinted towards a restrictive physiology and an infiltrative disease. Cardiac magnetic resonance imaging could not be done in view of the incompatible temporary pacemaker on which the patient was dependent. Abdominal fat pad biopsy was positive for amyloid. He was taken up for permanent pacemaker implantation; however, multiple attempts could not achieve desired threshold and capture amplitudes in the right ventricular apex, septum, or outflow region. The lead was placed in the coronary sinus and a stent was placed proximally to trap the lead behind the deployed stent. Threshold and impedance were satisfactory. Cardiac biopsy subsequently confirmed aTTR amyloidosis.
Discussion:
The patient had an ischaemic heart disease, conduction disease, and cardiomyopathy as the manifestation of cardiac amyloidosis. While two-dimensional echo is the screening tool of choice, cardiac biopsy remains the gold standard of diagnosis for amyloidosis. Cardiac pacing comes with its own unique set of challenges in patients with advanced amyloid cardiomyopathy and have to be overcome for symptomatic benefit of the patient. Coronary sinus may be utilized in such patients for single-site ventricular pacing and placing a stent may help to anchor the lead when placed within it.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VI: Nursing Management

